Inhalation of the endothelin-A receptor antagonist LU-135252 at various doses in experimental acute lung injury

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Deja, Maria ^a   Busch, Thilo ^a   Wolf, Steffen ^a   Donaubauer, Bernd ^a   Petersen, Bodil ^a   Skomrock, Joerg ^a   Boemke, Willehad ^a   Kaisers, Udo ^a,b  

^a University Medical Center Eppendorf   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute lung injury; Endothelin A (ETA) receptor antagonist; Gas exchange; Inhalation; Selective pulmonary vasodilation

Indexed keywords

DARUSENTAN; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; LUNG SURFACTANT;

ACUTE LUNG INJURY; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN TENSION; ARTIFICIAL VENTILATION; CONFERENCE PAPER; CONTROLLED STUDY; GAS EXCHANGE; HEART OUTPUT; LOW DRUG DOSE; LUNG ARTERIOVENOUS SHUNT; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG LAVAGE; MEAN ARTERIAL PRESSURE; NEBULIZATION; NONHUMAN; PRIORITY JOURNAL; SWINE;

ADMINISTRATION, INHALATION; ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODYNAMICS; NEBULIZERS AND VAPORIZERS; PHENYLPROPIONATES; PULMONARY GAS EXCHANGE; PYRIMIDINES; RECEPTOR, ENDOTHELIN A; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY SYSTEM AGENTS; SWINE; TIME FACTORS;

EID: 11144300323     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166261.42723.b7     Document Type: Conference Paper

References (12)

1. Ware LB, Matthay A. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-1339.
2. Rossaint R, Falke KJ, Lopez F, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993;328:399-405.
3. Zapol WM, Rimar S, Gillis N, Marletta M, Bosken CH. Nitric oxide and the lung. Am J Respir Crit Care Med. 1994;149:1375-1380.
4. Walmrath D, Schneider T, Schermully R, et al. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996;153:991-996.
5. Druml W, Steltzer H, Waldhäusl W, et al. Endothelin-1 in adult respiratory distress syndrome. Am Rev Respir Dis. 1993;148:1169-1173.
6. Langleben D, DeMarchie M, Laporta D, et al. Endothelin-1 in acute lung injury and the adult respiratory distress syndrome. Am Rev Respir Dis. 1993;148:1646-1650.
7. Webb DJ, Strachan FE. Clinical experience with endothelin antagonists. Am J Hypertens. 1998;11:71S-79S.
8. Kaisers U, Busch T, Wolf S, et al. Inhaled endothelin A antagonist improves arterial oxygenation in experimental acute lung injury. Intensive Care Med. 2000;26:1334-1342.
9. Deja M, Wolf S, Busch T, et al. The inhaled endothelin A receptor antagonist LU-135252 acts as a selective pulmonary vasodilator. Clin Sci (Lond). 2002;103:21S-24S.
10. Lachmann B, Robertson B, Vogel J. In-vivo lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol Scand. 1980;24:231-236.
11. Münter K, Ehmke H, Kichengast M. Maintenance of blood pressure in normotensive dogs by endothelin. Am J Physiol. 1999;276:H1022-H1027.
12. Verhaar MC, Strachan FE, Newby DE, et al. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation. 1998;97:752-756.